Newsroom
Featured News
- People15 August 2025
Lotus Honoured as One of Asia’s Best Workplaces for the Fourth Consecutive Year
- Investors11 August 2025
Lotus reports July 2025 Revenue of NT$2,397 Million
- Investors11 August 2025
Lotus Pharmaceutical Achieves New First-Half Record in Revenue for 2025, While Q2 Impacted by FX and Timing of Lenalidomide Sales
- Business10 July 2025
Lotus reports June 2025 Revenue of NT$1,044 Million
- Business04 July 2025
Seoul High Court rules in favour of Alvogen Korea and overturned allegations related to Arimidex and Casodex
- Business18 June 2025
Lotus Enters Exclusive Licensing Agreement with A Vietnamese Pharmaceutical for a Drug Portfolio in Vietnam
- Investors10 June 2025
Lotus reports May 2025 Revenue of NT$1,129 Million
- Business26 May 2025
Lotus Pharmaceutical Secures Approval for Bosutinib, addressing unmet needs in CML Market in Taiwan
- Investors09 May 2025
Lotus Sets Highest-Ever April Revenue of NT$2,573 Million
